SCHEMBL17816174

SCHEMBL17816174

O=C(Nc1ccc(F)c(Cl)c1)c1ccc(C(F)(F)I)c(SC2CCC(O)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MAOB P27338 3/20 0.42
KCNQ3 O43525 3/20 0.41
KCNQ2 O43526 3/20 0.41
KCNE1 P15382 3/20 0.41
KCNQ1 P51787 3/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAOA P21397 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CCR2 P41597 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17792181 0.92 NPC1 (0.47) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792161 0.88 NPC1 (0.53) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792173 0.87 NPC1 (0.52) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17816178 0.86 CYP1A2 (0.35) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17816106 0.86 NPC1 (0.49) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792172 0.84 NPC1 (0.49) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792170 0.84 NPC1 (0.49) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792133 0.84 TAS1R3 (0.47) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792185 0.84 NPC1 (0.47) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17792162 0.83 NPC1 (0.52) NPC1RAB9AMAOBKCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed